Atara Biotherapeutics, Inc. (LON:0HIY)

Atara Biotherapeutics Statistics

Total Valuation

LON:0HIY has a market cap or net worth of GBP 63.35 million. The enterprise value is 59.80 million.

Market Cap	63.35M
Enterprise Value	59.80M

Important Dates

The last earnings date was Thursday, November 6, 2025.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	7.02M
Shares Outstanding	n/a
Shares Change (YoY)	+103.16%
Shares Change (QoQ)	+13.45%
Owned by Insiders (%)	2.58%
Owned by Institutions (%)	28.46%
Float	4.42M

Valuation Ratios

The trailing PE ratio is 14.98 and the forward PE ratio is 9.23.

PE Ratio	14.98
Forward PE	9.23
PS Ratio	0.46
PB Ratio	-2.48
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.13, with an EV/FCF ratio of -1.28.

EV / Earnings	14.14
EV / Sales	0.42
EV / EBITDA	2.13
EV / EBIT	4.04
EV / FCF	-1.28

Financial Position

The company has a current ratio of 1.70

Current Ratio	1.70
Quick Ratio	1.53
Debt / Equity	n/a
Debt / EBITDA	0.48
Debt / FCF	-0.28
Interest Coverage	4.63

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	15.71%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	86.73%
Revenue Per Employee	3.62M
Profits Per Employee	111,310
Employee Count	153
Asset Turnover	2.45
Inventory Turnover	n/a

Taxes

Income Tax	-24,087
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +31.04% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+31.04%
50-Day Moving Average	13.57
200-Day Moving Average	9.67
Relative Strength Index (RSI)	34.72
Average Volume (20 Days)	837

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.24

Income Statement

In the last 12 months, LON:0HIY had revenue of GBP 137.71 million and earned 4.23 million in profits. Earnings per share was 0.41.

Revenue	137.71M
Gross Profit	4.05M
Operating Income	14.14M
Pretax Income	4.21M
Net Income	4.23M
EBITDA	17.50M
EBIT	14.14M
Earnings Per Share (EPS)	0.41

Balance Sheet

The company has 16.29 million in cash and 12.90 million in debt, giving a net cash position of 3.40 million.

Cash & Cash Equivalents	16.29M
Total Debt	12.90M
Net Cash	3.40M
Net Cash Per Share	n/a
Equity (Book Value)	-25.58M
Book Value Per Share	-3.67
Working Capital	7.45M

Cash Flow

In the last 12 months, operating cash flow was -46.65 million and capital expenditures -65,691, giving a free cash flow of -46.72 million.

Operating Cash Flow	-46.65M
Capital Expenditures	-65,691
Free Cash Flow	-46.72M
FCF Per Share	n/a

Margins

Gross margin is 2.94%, with operating and profit margins of 10.27% and 3.07%.

Gross Margin	2.94%
Operating Margin	10.27%
Pretax Margin	3.05%
Profit Margin	3.07%
EBITDA Margin	12.71%
EBIT Margin	10.27%
FCF Margin	n/a

Dividends & Yields

LON:0HIY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-103.16%
Shareholder Yield	-103.16%
Earnings Yield	6.68%
FCF Yield	-73.75%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 20, 2024. It was a reverse split with a ratio of 0.04.

Last Split Date	Jun 20, 2024
Split Type	Reverse
Split Ratio	0.04

Scores

LON:0HIY has an Altman Z-Score of -68.82 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-68.82
Piotroski F-Score	5